Roche Products Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
211 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Australian Public Assessment Report (AusPAR)New AusPAR for ACTEMRA Tocilizumab (rch) for the treatment of coronavirus disease 2019 (COVID-19).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROZLYTREK entrectinib 200 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROZLYTREK entrectinib 100 mg hard capsule bottle.
-
Prescription medicine registrationActive ingredients: tocilizumab.
-
Prescription medicine registrationActive ingredients: casirivimab; imdevimab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 40 mg film-coated tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Pertuzumab/trastuzumab